newsfilter
← Latest News
GlobeNewswire·

Design Therapeutics to Present at the 2023 Jefferies Healthcare Conference

CARLSBAD, Calif., May 31, 2023 (GLOBE NEWSWIRE) -- Design Therapeutics, Inc. (NASDAQ:DSGN), a clinical-stage biotechnology company developing treatments for serious degenerative genetic diseases, today reported that